BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

634 related articles for article (PubMed ID: 29987445)

  • 1. Biomarkers for the identification of cardiac fibroblast and myofibroblast cells.
    Tarbit E; Singh I; Peart JN; Rose'Meyer RB
    Heart Fail Rev; 2019 Jan; 24(1):1-15. PubMed ID: 29987445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Featured Article: TGF-β1 dominates extracellular matrix rigidity for inducing differentiation of human cardiac fibroblasts to myofibroblasts.
    Cho N; Razipour SE; McCain ML
    Exp Biol Med (Maywood); 2018 Apr; 243(7):601-612. PubMed ID: 29504479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad7 blocks transforming growth factor-β1-induced gingival fibroblast-myofibroblast transition via inhibitory regulation of Smad2 and connective tissue growth factor.
    Sobral LM; Montan PF; Zecchin KG; Martelli-Junior H; Vargas PA; Graner E; Coletta RD
    J Periodontol; 2011 Apr; 82(4):642-51. PubMed ID: 21054221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrins αvβ5 and αvβ3 promote latent TGF-β1 activation by human cardiac fibroblast contraction.
    Sarrazy V; Koehler A; Chow ML; Zimina E; Li CX; Kato H; Caldarone CA; Hinz B
    Cardiovasc Res; 2014 Jun; 102(3):407-17. PubMed ID: 24639195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of delta-like 1 homologue accelerates fibroblast-myofibroblast differentiation and induces myocardial fibrosis.
    Rodriguez P; Sassi Y; Troncone L; Benard L; Ishikawa K; Gordon RE; Lamas S; Laborda J; Hajjar RJ; Lebeche D
    Eur Heart J; 2019 Mar; 40(12):967-978. PubMed ID: 29668883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of miR-145 in cardiac myofibroblast differentiation.
    Wang YS; Li SH; Guo J; Mihic A; Wu J; Sun L; Davis K; Weisel RD; Li RK
    J Mol Cell Cardiol; 2014 Jan; 66():94-105. PubMed ID: 24001939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.
    Li J; Zhang W; Jiao R; Yang Z; Yuan Y; Wu Q; Hu Z; Xiang S; Tang Q
    Int J Clin Exp Pathol; 2015; 8(5):5121-8. PubMed ID: 26191207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cultured fetal fibroblasts have myofibroblast-associated characteristics and produce a fibrotic-like environment upon stimulation with TGF-β1: Is there a thin line between fetal scarless healing and fibrosis?
    Walraven M; Akershoek JJ; Beelen RH; Ulrich MM
    Arch Dermatol Res; 2017 Mar; 309(2):111-121. PubMed ID: 28004279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effects of relaxin on cardiac fibroblast-to-myofibroblast transition: an electrophysiological study.
    Squecco R; Sassoli C; Garella R; Chellini F; Idrizaj E; Nistri S; Formigli L; Bani D; Francini F
    Exp Physiol; 2015 Jun; 100(6):652-66. PubMed ID: 25786395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II upregulates fibroblast-myofibroblast transition through Cx43-dependent CaMKII and TGF-β1 signaling in neonatal rat cardiac fibroblasts.
    Cao L; Chen Y; Lu L; Liu Y; Wang Y; Fan J; Yin Y
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):843-852. PubMed ID: 30060053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of autophagy inhibits the conversion of cardiac fibroblasts to cardiac myofibroblasts.
    Gupta SS; Zeglinski MR; Rattan SG; Landry NM; Ghavami S; Wigle JT; Klonisch T; Halayko AJ; Dixon IM
    Oncotarget; 2016 Nov; 7(48):78516-78531. PubMed ID: 27705938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts.
    Cucoranu I; Clempus R; Dikalova A; Phelan PJ; Ariyan S; Dikalov S; Sorescu D
    Circ Res; 2005 Oct; 97(9):900-7. PubMed ID: 16179589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1.
    Ma J; Ma SY; Ding CH
    Chin J Integr Med; 2017 May; 23(5):362-369. PubMed ID: 26956464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human xylosyltransferase-I - a new marker for myofibroblast differentiation in skin fibrosis.
    Faust I; Roch C; Kuhn J; Prante C; Knabbe C; Hendig D
    Biochem Biophys Res Commun; 2013 Jul; 436(3):449-54. PubMed ID: 23747722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Role of Adenosine Receptors in the Myofibroblast Transformation in Peyronie's Disease.
    Mateus M; Ilg MM; Stebbeds WJ; Christopher N; Muneer A; Ralph DJ; Cellek S
    J Sex Med; 2018 Jul; 15(7):947-957. PubMed ID: 29891411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-β1/Smad2 and nuclear factor-κB signaling pathways in human fetal lung fibroblasts.
    Zhang Q; Tu W; Tian K; Han L; Wang Q; Chen P; Zhou X
    J Cell Biochem; 2019 Jan; 120(1):93-104. PubMed ID: 30230565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcription factor scleraxis is a critical regulator of cardiac fibroblast phenotype.
    Bagchi RA; Roche P; Aroutiounova N; Espira L; Abrenica B; Schweitzer R; Czubryt MP
    BMC Biol; 2016 Mar; 14():21. PubMed ID: 26988708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis.
    Liu X; Shen M; Qi Q; Zhang H; Guo SW
    Hum Reprod; 2016 Apr; 31(4):734-49. PubMed ID: 26908845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibroblast growth factor-2 regulates human cardiac myofibroblast-mediated extracellular matrix remodeling.
    Svystonyuk DA; Ngu JM; Mewhort HE; Lipon BD; Teng G; Guzzardi DG; Malik G; Belke DD; Fedak PW
    J Transl Med; 2015 May; 13():147. PubMed ID: 25948488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.